SiSaf closes a $4.3 million round
Clarendon portfolio company Sisaf has closed a $4.3million interim funding round led by Vickers Venture Partners with additional capital injections from Innovation Ulster Limited and Co-Fund NI, managed by Clarendon Fund Managers. SiSaf is a young, commercial stage company that develops drugs using bio-courier technology, ProSilic®, a novel method of drug delivery that is based on […]
SiSaf closes a $4.3 million round Read More »